Top Markets
#1 DogBull DogBull +105.13%
#2 ADO Protocol ADO Protocol +63.49%
#3 Siacoin Siacoin +43.24%
#4 MarsCoin MarsCoin +40.30%
#5 Useless Coin Useless Coin +29.99%
#6 UnifAI Network UnifAI Network +27.28%
#7 Ontology Gas Ontology Gas +21.51%
#8 Magma Finance Magma Finance +19.90%
#9 Falcon Finance Falcon Finance +16.16%
#10 Filecoin Filecoin +15.29%
Coin of the day
DogBull DogBull
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Newron Pharmaceuticals S.p.A. Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A.

NP5
Rang in Aktien #15973
Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in... Newron Pharmaceuticals SpA is a biopharmaceutical enterprise headquartered in Bresso, Milano, with a dedicated team of 24 full-time employees. The company's core mission is the discovery and advancement of innovative pharmaceutical products, particularly focusing on new therapies for Central Nervous System (CNS) disorders and pain management. Among its leading candidates, safinamide is currently undergoing Phase III clinical trials for the treatment of Parkinson's disease. Additionally, ralfinamide is being developed as a potential therapy for neuropathic pain. The firm's pipeline further includes a range of projects at various preclinical and clinical development stages, such as HF0220 for neuroprotection, NW-3509 for schizophrenia, and pruvanserin and sarizotan for other CNS conditions.
Aktienkurs
$15.42
Marktkapitalisierung
$320.83M
Veränderung (1 Tag)
-1.52%
Veränderung (1 Jahr)
40.67%
Land
IT
Handel Newron Pharmaceuticals S.p.A. (NP5)

Kategorie

Healthcare
Aktien-Split-Historie für Newron Pharmaceuticals S.p.A. (NP5)
Die Aktie Newron Pharmaceuticals S.p.A. (Symbol: NP5) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Sep 01, 2026 statt.
Eine NP5-Aktie, die vor dem Sep 01, 2026 gekauft wurde, entspricht heute 0 NP5-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH